
GENINUS Inc. — Investor Relations & Filings
GENINUS Inc. is a biotechnology company specializing in genomic and multi-omics analysis for precision medicine. The company provides comprehensive solutions for drug development, diagnostics, and clinical research, with a focus on single-cell analysis, cancer genome companion diagnostics, and AI-driven biomarker discovery. Its proprietary platforms include IntelliMed™ for clinical genomics, MEDINSIGHT™ for AI-powered digital pathology, and SPACEINSIGHT™, a cloud-based platform for spatial multi-omics data analysis. By integrating advanced analytics with artificial intelligence, GENINUS delivers genetic insights to support personalized treatment strategies, disease prevention, and the development of novel therapeutics.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 주요사항보고서(전환사채매수선택권행사자지정) | 2026-05-08 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-27 | Korean | |
| 주식등의대량보유상황보고서(약식) | 2026-04-01 | Korean | |
| 주식등의대량보유상황보고서(약식) | 2026-03-27 | Korean | |
| [기재정정]증권발행결과(자율공시) | 2026-03-26 | Korean | |
| [기재정정]증권발행결과(자율공시) | 2026-03-26 | Korean |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 44132211 | 주요사항보고서(전환사채매수선택권행사자지정) | 2026-05-08 | Korean | ||
| 37293421 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-27 | Korean | ||
| 33129696 | 주식등의대량보유상황보고서(약식) | 2026-04-01 | Korean | ||
| 33054581 | 주식등의대량보유상황보고서(약식) | 2026-03-27 | Korean | ||
| 33047653 | [기재정정]증권발행결과(자율공시) | 2026-03-26 | Korean | ||
| 33044803 | [기재정정]증권발행결과(자율공시) | 2026-03-26 | Korean | ||
| 33039173 | 증권발행결과(자율공시) | 2026-03-25 | Korean | ||
| 33038962 | 주식매수선택권부여에관한신고 | 2026-03-25 | Korean | ||
| 33018085 | 정기주주총회결과 | 2026-03-24 | Korean | ||
| 32991324 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-03-20 | Korean | ||
| 32956700 | 감사보고서제출 | 2026-03-16 | Korean | ||
| 32956199 | 사업보고서 (2025.12) | 2026-03-16 | Korean | ||
| 32919931 | 의결권대리행사권유참고서류 | 2026-03-10 | Korean | ||
| 32916565 | 주주총회소집공고 | 2026-03-09 | Korean | ||
| 32914460 | [첨부추가]주요사항보고서(유상증자결정) | 2026-03-09 | Korean | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
NANOVIRICIDES, INC.
Clinical-stage biopharma developing broad-spectrum, nanomed…
|
NNVC | US | Professional, scientific and te… |
|
Natcore Technology Inc.
R&D entity using nanotechnology to improve solar cell effic…
|
NTCXF | CA | Professional, scientific and te… |
|
Nautilus Biotechnology, Inc.
Develops a proteome analysis platform to quantify proteins …
|
NAUT | US | Professional, scientific and te… |
|
NeoImmuneTech, Inc.
A clinical-stage biopharma developing T cell-focused immuno…
|
950220 | US | Professional, scientific and te… |
|
Neovacs
Biotech firm developing immunotherapies and investing in Bi…
|
ALNEV | FR | Professional, scientific and te… |
|
NervGen Pharma Corp.
Clinical-stage biotech developing treatments to promote ner…
|
NGEN | CA | Professional, scientific and te… |
|
NEUREN PHARMACEUTICALS LIMITED
Develops innovative therapies for rare neurodevelopmental d…
|
NEU | NZ | Professional, scientific and te… |
|
NEURIZON THERAPEUTICS LIMITED
Clinical-stage developer of mTOR modulators for ALS and neu…
|
NUZ | AU | Professional, scientific and te… |
|
NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD
Develops peptide-based therapeutics for neurodegenerative a…
|
NSB | AU | Professional, scientific and te… |
|
NEUROTECH INTERNATIONAL LIMITED
Clinical-stage biopharmaceutical company developing pediatr…
|
NTI | AU | Professional, scientific and te… |
GENINUS Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/15755/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=15755 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=15755 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=15755 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 15755}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GENINUS Inc. (id: 15755)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.